1Vanlet P,Horny HP, Bennet JM, et al. Definitions and standards in the diagnosis and treatment of myelodysplastic syndromes : Consensus state- ments and report from a working conference [J]. Leuk Res, 2007,31 (4) :727 -736.
2Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes [J]. Br J Haematol, 1982,51 ( 2 ) : 189 - 199.
3Cermak J, Miehalova K, Brezinova J, et al. A prognostic impact of the separation of refractory cytopenia with multilineage dysplasia and 5q - syndrome from refractory anemia in primary myelodysplastic syndrome [ J ]. Leuk Res,2003,27 ( 2 ) : 221 - 229.
4Brunning RD, Bennett JM, Flandrin G, et al. World Health Organization of tumors, pathology and genetics of tumors, of haematopoietic and lymphoid tissues [ M ]. Lyon : IARC Press,2001:61 - 73.
5Vardeman JW. Hematopathological concepts and controversies in the diagnosis and classification of myelodysplastic syndromes [ J ]. Hematol Am Soc Hematol Educ Program ,2006 :199 -204.
6Nosslinger T, Reisner R, Koller E,et al. Myelodysplastic syndromes from French- American -British to World Health Organization: Comparison of classifications on 431 unselected patients from a single institution [J]. Blood,2001,98 (10) :2935 - 2941.
7Germing U,Strupp C,Kuenglen A,et al. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes[J]. Haematologica ,2006,91 (12) :1596 - 1604.
